Dechra Pharmaceuticals PLC Holding(s) in Company
January 18 2024 - 5:11AM
RNS Non-Regulatory
Dechra Pharmaceuticals PLC
18 January 2024
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB0009633180
Issuer Name
DECHRA PHARMACEUTICALS PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Bank of America Corporation
City of registered office (if applicable)
Country of registered office (if applicable)
US
4. Details of the shareholder
Full name of shareholder(s) if different from the person(s)
subject to the notification obligation, above
City of registered office (if applicable)
Country of registered office (if applicable)
5. Date on which the threshold was crossed or reached
16-Jan-2024
6. Date on which Issuer notified
17-Jan-2024
7. Total positions of person(s) subject to the notification
obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 0.000000 0.972033 0.972033 1107203
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable) 6.055482 1.003390 7.058872
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
Sub Total 8.A
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect
according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Swaps 17/04/2024 N/A Cash 437610 0.384186
================ ==================== ================== ================== ==================
Swaps 31/07/2024 N/A Cash 324556 0.284933
================ ==================== ================== ================== ==================
Swaps 08/11/2024 N/A Cash 20000 0.017558
================ ==================== ================== ================== ==================
Swaps 02/12/2024 N/A Cash 10000 0.008779
================ ==================== ================== ================== ==================
Swaps 17/12/2024 N/A Cash 236516 0.207642
================ ==================== ================== ================== ==================
Swaps 18/12/2024 N/A Cash 41053 0.036041
================ ==================== ================== ================== ==================
Swaps 23/12/2024 N/A Cash 33840 0.029709
================ ==================== ================== ================== ==================
Swaps 30/12/2024 N/A Cash 1745 0.001532
================ ==================== ================== ================== ==================
Swaps 02/01/2025 N/A Cash 1129 0.000991
================ ==================== ================== ================== ==================
Swaps 03/02/2025 N/A Cash 496 0.000435
================ ==================== ================== ================== ==================
Swaps 04/02/2025 N/A Cash 258 0.000227
================ ==================== ================== ================== ==================
Sub Total 8.B2 1107203 0.972033%
================== ==================
9. Information in relation to the person subject to the
notification obligation
2. Full chain of controlled undertakings through which the
voting rights and/or the financial instruments are effectively held
starting with the ultimate controlling natural person or legal
entities (please add additional rows as necessary)
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it
person undertaking it equals or is higher through financial equals or is higher
than the notifiable instruments if it than the notifiable
threshold equals or is higher threshold
than the notifiable
threshold
Bank of America Bank of America,
Corporation National
Association
====================== ====================== ====================== ======================
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
17-Jan-2024
13. Place Of Completion
United Kingdom
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAQKFBKKBKDADD
(END) Dow Jones Newswires
January 18, 2024 05:11 ET (10:11 GMT)